About Us:

VetMotl, Inc. (www.vetmotl.com), established in December 2022, is commercializing first-of-their-kind VetMotl® Sperm Separation Devices for use in veterinary assisted reproductive technology (ART) procedures. VetMotl devices are derived from the core technology inherent in ZyMōt® Sperm Separation Devices, which have been used in more than 1,000 human fertility clinics worldwide for over 10 years, demonstrating time-proven, consistent performance in over 1.5 million clinical cases to date. 

We are a Germantown, Maryland, USA-based and globally recognized company who pioneered this innovative, game-changing laboratory tool for preparing high-quality, highly-motile sperm samples for veterinary assisted reproduction.

VetMotl devices have been proven to deliver increased efficiencies in blast development and viable implantable embryos in equine and bovine fertility procedures, with demonstrated effectiveness in other animal species as well (e.g., small ruminants (ovine, caprine) and porcine). VetMotl devices provide considerable time savings and performance improvements when compared to traditional sperm sample preparation methods.

VetMotl, Inc.

Org chart

Teams

Offices